Literature DB >> 16199793

Family education for people with schizophrenia in Beijing, China: randomised controlled trial.

Zheng Li1, David Arthur.   

Abstract

BACKGROUND: Much of China lacks well-developed services for people with schizophrenia and their families, and most of the existing services focus on hospitals. There is a need for culturally sensitive family treatments offered by nurses. AIMS: To conduct a longitudinal experimental study examining the effect of patient and family education in a sample of Chinese people with schizophrenia.
METHOD: A randomised controlled trial was conducted in a large hospital with a was conducted in a large hospital with a sample of 101 patients with schizophrenia and their families. Data were collected at admission and at discharge, and then at 3 and 9 months after discharge. The intervention group received family education, and data on their knowledge about schizophrenia, symptoms, functioning, psychosocial behaviour, relapse and medication adherence were collected and compared with the control group.
RESULTS: There was a significant improvement in knowledge about schizophrenia in the experimental group and a significant difference in symptom scores and functioning at 9 months after discharge. Patients who were nonadherent to medication regimens were more likely to relapse.
CONCLUSIONS: Family education on schizophrenia by nurses in China was effective in improving knowledge and promoting improvement in patients' symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 16199793     DOI: 10.1192/bjp.187.4.339

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  22 in total

1.  The Effects of Group Psychoeducational Programme on Attitude toward Mental Illness in Families of Patients with Schizophrenia, 2014.

Authors:  Farnaz Rahmani; Fatemeh Ranjbar; Hossein Ebrahimi; Mina Hosseinzadeh
Journal:  J Caring Sci       Date:  2015-09-01

2.  Using focus groups to design a psychoeducation program for patients with schizophrenia and their family members.

Authors:  Yan Song; Dan Liu; Yuxiang Chen; Guoping He
Journal:  Int J Clin Exp Med       Date:  2014-01-15

Review 3.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

4.  Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.

Authors:  Kit Wa Sherry Chan; Men Heng Marian Wong; Christy Lai Ming Hui; Edwin Ho Ming Lee; Wing Chung Chang; Eric Yu Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-24       Impact factor: 4.328

5.  Clinical correlates of the caregiving experience for Chinese caregivers of patients with schizophrenia.

Authors:  Victoria Wing Kay Tang; Siu Kau Leung; Linda Chiu-Wa Lam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-04-26       Impact factor: 4.328

6.  The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

7.  Customising informed consent procedures for people with schizophrenia in India.

Authors:  Sudipto Chatterjee; Berit Kieselbach; Smita Naik; Shuba Kumar; Sujit John; Madhumitha Balaji; Mirja Koschorke; Hamid Dabholkar; Mathew Varghese; Vikram Patel; Graham Thornicroft; Rangaswamy Thara
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-03-04       Impact factor: 4.328

Review 8.  Effect of psychosocial interventions on social functioning in depression and schizophrenia: meta-analysis.

Authors:  Mary J De Silva; Sara Cooper; Henry Lishi Li; Crick Lund; Vikram Patel
Journal:  Br J Psychiatry       Date:  2013-04       Impact factor: 9.319

9.  The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.

Authors:  Ryan McBain; Daniel J Norton; Jodi Morris; M Taghi Yasamy; Theresa S Betancourt
Journal:  PLoS Med       Date:  2012-01-31       Impact factor: 11.069

10.  Packages of care for schizophrenia in low- and middle-income countries.

Authors:  Mari Jair de Jesus; Denise Razzouk; Rangaswamy Thara; Julian Eaton; Graham Thornicroft
Journal:  PLoS Med       Date:  2009-10-20       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.